Healthcare -
Biotechnology - NASDAQ - US
$ 7.48
2.89 %
$ 511 M
Market Cap
-3.76
P/E
EYPT - CASH & EQUIVALENTS
Cash & Equivalents EYPT - EyePoint Pharmaceuticals, Inc.
281 M
LAST VALUE
25.49%
2 YEAR CAGR
48.63%
5 YEAR CAGR
44.89%
10 YEAR CAGR